PhRMA-backed lobbying blocks 'most favored nation' drug pricing by en…

Market overview

Pharmaceutical industry leaders oppose Trump’s proposal for a 'most favored nation' drug pricing policy, citing potential market disruptions and care rationing. Given Republican opposition and industry lobbying, Congress is unlikely to pass the policy.

regulatory prediction market

Implied probability (Yes)

80%

More regulatory markets

• UK government increases teacher pay offer by 2%+ in 2027 — 45% Yes
• FIFA issues formal disciplinary action against Trump by 2026-12-31 — 70% Yes
• UK government to allocate £200M for river clean-up by 2026 — 70% Yes
• FIFA issues formal reprimand against U.S. Soccer for Trump interference — 75% Yes
• Trump administration implements AI guardrails by Q4 2026 — 70% Yes
• Senate blocks OMB grant rule by December 2026 — 72% Yes
• Biden administration approves ICE detention project within 6 months — 40% Yes
• Forge Global secures Anthropic approval within 6 months — 75% Yes

Browse all regulatory markets →